Delivery Order HHSN261201500003I-HHSN26100030
Award Date 9/22/16
Potential Completion Date 9/21/21
Potential Value $64M
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Frederick, MD 21702, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Economy Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $14,640,019.00 cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Leidos Biomedical Research Inc. to manufacture and test Zika virus or Zika-related virus vaccine products. The contract is not set aside. Leidos Biomedical Research, a subsidiary of Leidos Holdings Inc., has a history of supporting federal biomedical research programs at...
- This is a federal contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Leidos Biomedical Research Inc. for the development of a live attenuated Zika vaccine in Brazil. The $12,038,844.00 contract is a cost-plus-fixed-fee delivery order that runs from September 2017 to September 2022. Leidos Biomedical Research Inc. is a subsidiary of Leidos Holdings, Inc. and has performed extensive research and...
- This is a $2,392,433.00 cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for work related to the "ZIKA MEXICO" project and the place of performance is Fort Detrick, MD. This contract does not have a set-aside designation. Leidos Biomedical Research Inc. is an...
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The $13,618,140.00 contract supports the NIAID's mission of research and development of vaccines and therapeutics for diseases of human concern, including malaria. The contract does not have a set-aside designation. Leidos Biomedical Research Inc. is a Federally Funded Research and...
- This federal contract award supports the National Institute of Allergy and Infectious Diseases' (NIAID's) goal to conduct a series of standardized Phase 1 and Phase 2 trials on next-generation vaccines. The $173,281,267.00 cost-plus-fixed-fee delivery order was awarded to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. that serves as a Federally Funded Research and Development Center (FFRDC) contractor for the National Cancer Institute (NCI). The contract has an ultimate...
- This is a $8,782,079.00 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Leidos Biomedical Research Inc. The contract is for research, development, and production to support clinical trials for HIV vaccines. Leidos Biomedical Research Inc. is a subsidiary of Leidos Holdings, Inc. and operates as a Federally Funded Research and Development Center (FFRDC) contractor for the National Cancer...
- This is a $87,099,419.00 cost-plus-fixed-fee delivery order contract awarded to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH). The contract is for the NIAID Vaccine Research Center (VRC) operational support in fiscal years 2026 and 2027, with a completion date of August 30, 2027. The contract does not have a set-aside designation,...
- This is a $162,950,791.20 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Leidos, Inc. Research And Development Division. The contract is for biomedical (basic) research and development services, and does not have a set-aside designation. The contract is associated with larger contract vehicles, including the One Acquisition Solution for Integrated Services (OASIS) and Alliant II Governmentwide...
- This is a $23,855,636.00 Cost Plus Fixed Fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for research, development, and production to support clinical trials for HIV vaccines. This work is being performed at Leidos Biomedical Research facilities in Frederick, Maryland. The contract does not have...
- This is a $69,299,577.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Leidos Biomedical Research Inc. The contract supports NIAID's Division of Clinical Research (DCR) operational requirements and has an ultimate completion date of August 30, 2025. Leidos Biomedical Research Inc. is a subsidiary of Leidos Holdings, Inc. and serves as a Federally Funded Research and...